Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

Summary by The Manila Times
Subjects dosed in Phase 1 study evaluating safety and tolerability of a first-in-class multispecific antibody WESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics...

1 Articles

The Manila TimesThe Manila Times
Lean Right

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

Subjects dosed in Phase 1 study evaluating safety and tolerability of a first-in-class multispecific antibody WESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics...

·Manila, Philippines (the)
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Manila Times broke the news in Manila, Philippines (the) on Wednesday, April 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Coronavirus icon

Coronavirus

Weston, Massachusetts icon

Weston, Massachusetts

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal